Characterization of α‐synuclein aggregation and synergistic toxicity with protein tau in yeastPiotr Zabrocki, Joris Winderickx, Fred Van Leuven et al.|FEBS Journal|2005Cited by 110
A yeast-based model of α-synucleinopathy identifies compounds with therapeutic potentialGerard Griffioen, Stefaan Wera, Hein Duhamel et al.|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2005Cited by 86
Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer’s diseaseKatrien Princen, Gerard Griffioen|Science|2024Cited by 56
Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse ModelAn Tanghe, Tom Van Dooren, Gerard Griffioen et al.|International Journal of Alzheimer s Disease|2010Cited by 30